Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.

Hou H, Khan N, O'Hara JA, Grinberg OY, Dunn JF, Abajian MA, Wilmot CM, Demidenko E, Lu S, Steffen RP, Swartz HM.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1503-9.

PMID:
15817356
2.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
3.

Role of efaproxiral in metastatic brain tumors.

Engel RH, Kaklamani VG.

Expert Rev Anticancer Ther. 2006 Apr;6(4):477-85. Review.

PMID:
16613536
4.

Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.

Charpentier MM.

Ann Pharmacother. 2005 Dec;39(12):2038-45. Epub 2005 Oct 25. Review.

PMID:
16249270
5.

Efaproxiral (Allos Therapeutics).

Kolman A.

IDrugs. 2003 Aug;6(8):795-801. Review.

PMID:
12917776
6.

Impact of hemoglobin levels on tumor oxygenation: the higher, the better?

Vaupel P, Mayer A, Höckel M.

Strahlenther Onkol. 2006 Feb;182(2):63-71. Review.

PMID:
16447012
7.

Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications.

Gallez B, Baudelet C, Jordan BF.

NMR Biomed. 2004 Aug;17(5):240-62. Review.

PMID:
15366026
8.

The measurement of oxygen in vivo using EPR techniques.

Swartz HM, Clarkson RB.

Phys Med Biol. 1998 Jul;43(7):1957-75. Review.

PMID:
9703059
9.

In vivo EPR spectroscopy: biomedical and potential diagnostic applications.

Jackson SK, Thomas MP, Smith S, Madhani M, Rogers SC, James PE.

Faraday Discuss. 2004;126:103-17; discussion 169-83. Review.

PMID:
14992402
11.
12.

Developing in vivo EPR oximetry for clinical use.

Swartz HM, Walczak T.

Adv Exp Med Biol. 1998;454:243-52. Review.

PMID:
9889898
13.

Oxygen delivery to tumors.

Hirst DG.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1271-7. Review.

PMID:
3531111
14.

Oxygenation status of urogenital tumors.

Vaupel P, Hoeckel M, Mayer A.

Adv Exp Med Biol. 2011;701:101-6. doi: 10.1007/978-1-4419-7756-4_14. Review.

PMID:
21445775
15.

Clinical applications of EPR: overview and perspectives.

Swartz HM, Khan N, Buckey J, Comi R, Gould L, Grinberg O, Hartford A, Hopf H, Hou H, Hug E, Iwasaki A, Lesniewski P, Salikhov I, Walczak T.

NMR Biomed. 2004 Aug;17(5):335-51. Review.

PMID:
15366033
16.

Novel radiosensitizers for tumors of the central nervous system.

Mehta MP, Suh JH.

Curr Opin Investig Drugs. 2004 Dec;5(12):1284-91. Review.

PMID:
15648950
17.

Physiological mechanisms underlying heat-induced radiosensitization.

Vujaskovic Z, Song CW.

Int J Hyperthermia. 2004 Mar;20(2):163-74. Review.

PMID:
15195511
18.

Tumor oxygenation status as a prognostic marker.

Menon C, Fraker DL.

Cancer Lett. 2005 Apr 28;221(2):225-35. Review.

PMID:
15808408
19.

Tissue oxygenation in sepsis; new insights from in vivo EPR.

James PE, Thomas MP, Jackson SK.

NMR Biomed. 2004 Aug;17(5):319-26. Review.

PMID:
15366031
20.

[Techniques for automatic recording of the oxygen equilibrium curve: precision determination of gaseous ligand binding (1)].

Imai K.

Tanpakushitsu Kakusan Koso. 1999 Apr;44(5):706-13. Review. Japanese. No abstract available.

PMID:
10332232
Items per page

Supplemental Content

Write to the Help Desk